A Phase IIIb, open-label, run-in and double-blind, placebo-controlled, randomized study to evaluate the safety and efficacy of certolizumab pegol administered concomitantly with stable-dose methotrexate in patients with active rheumatoid arthritis A Phase IIIb, open-label, run-in and double-blind, placebo-controlled, randomized study to evaluate ...
A Phase IIIb, open-label, run-in and double-blind, placebo-controlled, randomized study to evaluate the safety and efficacy of certolizumab pegol administered concomitantly with stable-dose methotrexate in patients with active rheumatoid arthritis A Phase IIIb, open-label, run-in and double-blind, placebo-controlled, randomized study to evaluate ...
Product Name: certolizumab pegol Product Code: CDP870 INN or Proposed INN: Certolizumab pegol Other descriptive name: Anti-TNF humanized antibody Fab' fragment - PEG conjugateProduct Name: certolizumab pegol Product Code: CDP870 INN or Proposed INN: Certolizumab pegol Other des ...